HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.

Abstract
The structurally simple glycero- and sphingo-phospholipids, lysophosphatidic acid (LPA) and sphingosine-1-phosphate, serve as important receptor-active mediators that influence blood and vascular cell function and are positioned to influence the events that contribute to the progression and complications of atherosclerosis. Growing evidence from preclinical animal models has implicated LPA, LPA receptors, and key enzymes involved in LPA metabolism in pathophysiologic events that may underlie atherosclerotic vascular disease. These observations are supported by genetic analysis in humans implicating a lipid phosphate phosphatase as a novel risk factor for coronary artery disease. In this review, we summarize current understanding of LPA production, metabolism, and signaling as may be relevant for atherosclerotic and other vascular disease.
AuthorsSusan S Smyth, Paul Mueller, Fanmuyi Yang, J Anthony Brandon, Andrew J Morris
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 34 Issue 3 Pg. 479-86 (Mar 2014) ISSN: 1524-4636 [Electronic] United States
PMID24482375 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Apolipoproteins E
  • Lysophospholipids
  • sphingosine 1-phosphate
  • lipid phosphate phosphatase
  • PLPP3 protein, human
  • Phosphatidate Phosphatase
  • Plpp3 protein, mouse
  • Phosphoric Diester Hydrolases
  • alkylglycerophosphoethanolamine phosphodiesterase
  • Sphingosine
  • lysophosphatidic acid
Topics
  • Adipose Tissue (enzymology)
  • Animals
  • Apolipoproteins E (deficiency)
  • Atherosclerosis (genetics, metabolism)
  • Coronary Artery Disease (epidemiology, genetics, prevention & control)
  • Genetic Predisposition to Disease
  • Humans
  • Lysophospholipids (metabolism, physiology)
  • Mice
  • Mice, Knockout
  • Phosphatidate Phosphatase (deficiency, genetics, physiology)
  • Phosphoric Diester Hydrolases (physiology)
  • Plaque, Atherosclerotic (metabolism)
  • Risk
  • Sphingosine (analogs & derivatives, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: